From the TMS Board > Board News > 2004 Board News

2004 Board News

New TMS web site has been launched

August 18, 2004
On behalf of the members of the Board of Directors, I am pleased to announce that the Mastocytosis Society (TMS) has launched their brand new web site! After months of hard work from both the Board and the Research Subcommittee, we are proud to bring you up-to-date TMS information and important disease-related information on this new site. More

2004 Election

June 15, 2004
We will be sending out ballots at the end of July for the upcoming election of Directors to be ratified at the Annual Meeting in October. Currently, we have two vacancies on the Board. More

Critical Therapeutics Awards TMS $4,000

May 10, 2004
Valerie Slee, Co/ Vice Chair, and Rita Barlow, Chair, are happy to announce receipt of an unspecified educational grant to TMS from Critical Therapeutics of Cambridge, Massachusetts. The grant is in the amount of $4,000 and can be used for various patient education initiatives, including printing and mailing The Chronicles. More

TMS Awards Dr. Cem Akin $44,000 Research Grant

May 1, 2004
On behalf of the members of the Board of Directors, I am pleased to announce that the Mastocytosis Society (TMS) has awarded a research grant in the amount of $44,000 to Dr. Cem Akin. Dr. Akin was recently appointed Assistant Professor in the Department of Medicine, Division of Allergy and Clinical Immunology, at the prestigious University of Michigan. This appointment follows a successful stint at the National Institute of Allergy and Infectious Diseases, National Institutes of Health, where Dr. Akin established himself as a leading mast cell researcher and developed novel techniques for identifying mast cell disease and determining the most promising treatment options for patients. More

The Zyflo Situation

May 1, 2004
We were greatly distressed to find out that Abbott Pharmaceuticals discontinued production of Zileutin™ last summer. We were only made aware of it in January 2004 as the available supply had run out and our prescriptions could be filled. More